Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Sigyn Therapeutics develops medical devices focused on blood purification to treat infectious diseases, sepsis, and inflammatory disorders. Its flagship Sigyn Therapy extracts pathogens, toxins, and cytokines from blood, addressing unmet needs like viral infections, antibiotic resistance, and sepsis. The company also innovates devices to enhance cancer drug delivery and reduce toxicity, targeting global health challenges with broad-spectrum, extracorporeal solutions.
This description was generated via AI from an annual report. Updated about 1 year ago.